Priorities for vaginal microbicide research.
نویسندگان
چکیده
منابع مشابه
Thinking About Vaginal Microbicide Testing
A vaginal microbicide could slow the spread of HIV. To date, volunteers in placebo-controlled trials of candidate microbicides have been counseled to use condoms. This does not reduce the number of volunteers exposed to possible risk, but it shifts the allotment of risk from those conducting the trial to those women who may be least able to make autonomous decisions. Alternative ways of meeting...
متن کاملVaginal Microbicide Preferences Among Midwestern Urban
Purpose—The purpose of this study was to assess adolescent women’s preferences for specific microbicide characteristics including: pregnancy prevention, timing of application, potential for side effects, and whether it targeted Human Immunodeficiency Virus (HIV) or other sexually transmitted infections (STI). Potential differences in microbicide preferences by adolescent age group and behaviora...
متن کاملPriorities for Endometriosis Research
Endometriosis is an estrogen-dependent disorder where endometrial tissue forms lesions outside the uterus. Endometriosis affects an estimated 10% of women in the reproductive-age group, rising to 30% to 50% in patients with infertility and/or pain, with significant impact on their physical, mental, and social well-being. There is no known cure, and most current medical treatments are not suitab...
متن کاملThe Acceptability of a Vaginal Microbicide Among South African Men
statistician, Amy Andrews is a visiting student and Landon Myer is social scientist, all with the HIV Prevention and Vaccine Research Unit, Medical Research Council, Durban, South Africa. Amy E. Weber is a researcher with the Department of Epidemiology and Biostatistics, McGill University, Montreal, Canada. The authors would like to thank Joanne Mantell for her assistance with this article and ...
متن کاملMicrobicide vaginal rings: Technological challenges and clinical development.
Vaginal rings (VRs) are flexible, torus-shaped, polymeric devices designed to sustain delivery of pharmaceutical drugs to the vagina for clinical benefit. Following first report in a 1970 patent application, several steroid-releasing VR products have since been marketed for use in hormone replacement therapy and contraception. Since 2002, there has been growing interest in the use of VR technol...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: American Journal of Public Health
سال: 1995
ISSN: 0090-0036,1541-0048
DOI: 10.2105/ajph.85.5.737